ALGERT GLOBAL LLC

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1275218 SAN FRANCISCO, CA

Position in MDGL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,718,240

-$2,553,275 QoQ

Shares Held

3,200

-60.8% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#167

of 411 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. MDGL ranks #71 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	515,343	$29,956,888
2	ROIV	Roivant Sciences Ltd.	845,118	$29,908,726
3	XENE	Xenon Pharmaceuticals Inc.	419,773	$25,337,498
4	CLDX	Celldex Therapeutics, Inc.	647,836	$24,105,977
5	AXSM	Axsome Therapeutics, Inc.	95,335	$23,335,147
6	SNDX	Syndax Pharmaceuticals Inc	1,051,465	$22,985,024
7	MRNA	Moderna, Inc.	274,820	$19,245,644
8	MLYS	Mineralys Therapeutics, Inc.	649,027	$17,510,748

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,718,240	3,200	-60.8%	Shares	Sole	2026-08-13
2026-03-31	$4,271,515	8,160	-9.0%	Shares	Sole	2026-08-11
2025-12-31	$5,223,589	8,970	+11.7%	Shares	Sole	2026-08-11
2025-09-30	$3,683,039	8,030	-15.7%	Shares	Sole	2026-08-11
2025-06-30	$2,884,159	9,530	-2.5%	Shares	Sole	2026-08-11
2025-03-31	$3,236,117	9,770	0.0%	Shares	Sole	2026-08-11
2024-12-31	$3,014,728	9,770	+669.9%	Shares	Sole	2026-08-11
2024-06-30	$355,523	1,269	-82.9%	Shares	Sole	2026-08-11
2023-06-30	$1,711,941	7,411	-24.9%	Shares	Sole	2026-08-11
2023-03-31	$2,390,379	9,867	+14.1%	Shares	Sole	2026-08-11
2022-12-31	$2,510,662	8,650	-6.4%	Shares	Sole	2026-08-11
2022-09-30	$600,507	9,240	+91.6%	Shares	Sole	2022-11-15
2022-06-30	$345,230	4,823	0.0%	Shares	Sole	2022-08-15
2022-03-31	$473,232	4,823	-10.8%	Shares	Sole	2022-05-16
2021-12-31	$458,358	5,409	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.